Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Ficus Septica Exudate Antiseptic Plant Exudates

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (2)

Trial Status

Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07264686Phase 2Active Not RecruitingPrimary

Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second Trial

NCT06690814Phase 2CompletedPrimary

Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG

Showing all 2 trials

Research Network

Common Treatments

  • Ficus Septica Exudate Antiseptic Plant Exudates1
  • Pterocarpus Indicus Exudate1
  • Curcuma Longa Aqueous Extract1
  • Savlon Antiseptic Cream Cetrimide With Chlorhexidine Digluconate1
  • Active Comparator Savlon Antiseptic Cream Cetrimide With Chlorhexidine Digluconate1

Active Sponsors

  • Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia2
  • The Royal Botanic Gardens, Kew2

Related Conditions

  • Skin Sores2

Activity Timeline